Dr Luke Tregilgas
- BSc (Hons) Pharmacology, University of Liverpool
- MRes Biomedical Science and Translational Medicine, University of Liverpool
- MRes Post-Genomic Science, University of Liverpool/Newcastle University
- PhD Musculoskeletal Biology, University of Liverpool/Newcastle University
Luke Tregilgas joined Murgitroyd in February 2019 following the acquisition of Chapman IP by Murgitroyd. Luke joined Chapman IP after completing PhD training in Life Sciences at the University of Liverpool. He is one of our Patent Associates, currently working towards becoming a fully qualified patent attorney.
After studying Pharmacology as an undergraduate, Luke obtained Masters of Research degrees in Post-Genomic Science and Translational Medicine. Luke’s PhD training spanned the topic of musculoskeletal ageing, with a particular focus on multi-omics approaches to investigating the epigenetic effects of glucose on musculoskeletal cells. Luke is based in the Southampton Office.
Core Expertise: Molecular biology, biochemistry, microbiology, genetics, omics, pharmacology, toxicology, plant biology, biopesticides, medical devices, optics, green technologies, computer implemented inventions, mechanical inventions.